Key Takeaways Rapid adoption of EMROSI and expanded insurance coverage are driving strong revenue growth and positioning the company to benefit from increased dermatology demand. Financial discipline and operational leverage support profitability while mitigating risks from legacy products, enhancing earnings resilience and reducing potential dilution.Read more
